Fundraising FoxLabcyte
AcquiredSunnyvale, US · 4 known investors
Find your way into Labcyte
Sign up to see every warm intro you have to Labcyte
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Labcyte team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Beckman Coulter Life Sciences January 2019 · terms undisclosed — undisclosed · source ↗
Labcyte developed acoustic droplet ejection ("Echo") liquid-handling instruments that use focused sound waves to transfer nanoliter-scale liquid volumes between microplates without physical contact. Its technology served drug discovery, genomics, and proteomics workflows in pharma, biotech, and academic labs.
Founders & leadership
Board
Investors · 4
How we know: DBL Partners's portfolio page · Not right? Tell us
How we know: Seroba Life Sciences's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2016
▶$5MraisedJan 2017 · 1 investors · BiotechnologyRule 506(b)
- Joseph SmithDirector
- Tammy CameronExecutive Officer
- Joe KeeganDirector
- Sandra PanemDirector
- Mark Fischer-ColbrieExecutive Officer, Director
- Richard EllsonExecutive Officer, Director
- Craig TaylorDirector
- Offering amount
- $10M
- Amount sold
- $5M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Labcyte went on to found or lead other companies.
Frequently asked questions
- What does Labcyte do?
- Labcyte developed acoustic droplet ejection ("Echo") liquid-handling instruments that use focused sound waves to transfer nanoliter-scale liquid volumes between microplates without physical contact. Its technology served drug discovery, genomics, and proteomics workflows in pharma, biotech, and academic labs.
- Who founded Labcyte?
- Labcyte was founded by Richard Ellson.
- Who are Labcyte's investors?
- Labcyte's investors include DBL Partners, Seroba Life Sciences, GE Ventures, JP Morgan Chase.
- How much funding has Labcyte raised?
- Labcyte has disclosed $5M raised across 1 round.
- Where is Labcyte headquartered?
- Labcyte is headquartered in Sunnyvale, US.